| Kami Opal Moore, CNS | |
|
1265 S Utica Ave, Suite 300, Tulsa, OK 74104-4243 | |
| (918) 592-0999 | |
| (918) 392-0341 |
| Full Name | Kami Opal Moore |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 18 Years |
| Location | 1265 S Utica Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639390768 | NPI | - | NPPES |
| OK700116 | Other | OK | MEDICARE PTAN |
| P00637856 | Other | OK | MEDICARE RAILROAD |
| 200112940A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | R0075063 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hillcrest Medical Center | Tulsa, OK | Hospital |
| Hillcrest Hospital Claremore | Claremore, OK | Hospital |
| Bailey Medical Center, Llc | Owasso, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ahs Claremore Regional Hospital Llc | 4284809278 | 20 |
| Ahs Oklahoma Heart Llc | 4587737135 | 109 |
News Archive
Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).
A special Medicare program that stresses home health visits for patients with chronic diseases helped keep diabetes patients out of the hospital and may have lowered costs using time-honored prevention methods, researchers reported on Monday.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world.
› Verified 8 days ago
| Entity Name | Ahs Oklahoma Heart Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780857540 PECOS PAC ID: 4587737135 Enrollment ID: O20080716000032 |
News Archive
Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).
A special Medicare program that stresses home health visits for patients with chronic diseases helped keep diabetes patients out of the hospital and may have lowered costs using time-honored prevention methods, researchers reported on Monday.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world.
› Verified 8 days ago
| Entity Name | Ahs Claremore Regional Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316579642 PECOS PAC ID: 4284809278 Enrollment ID: O20200505000194 |
News Archive
Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).
A special Medicare program that stresses home health visits for patients with chronic diseases helped keep diabetes patients out of the hospital and may have lowered costs using time-honored prevention methods, researchers reported on Monday.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kami Opal Moore, CNS 1265 S Utica Ave, Suite 300, Tulsa, OK 74104-4243 Ph: (918) 592-0999 | Kami Opal Moore, CNS 1265 S Utica Ave, Suite 300, Tulsa, OK 74104-4243 Ph: (918) 592-0999 |
News Archive
Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).
A special Medicare program that stresses home health visits for patients with chronic diseases helped keep diabetes patients out of the hospital and may have lowered costs using time-honored prevention methods, researchers reported on Monday.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world.
› Verified 8 days ago
Teressa Headrick Lemaster, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1705 E 19th St, Suite 302, Tulsa, OK 74104 Phone: 918-748-7585 Fax: 918-748-7539 | |
Lisa Darcell Davis, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6161 S Yale Ave, Suite A100, Tulsa, OK 74136 Phone: 918-494-8500 Fax: 918-307-5578 | |
Suzanne Kirby, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave Ste 1105, Tulsa, OK 74104 Phone: 918-579-5749 | |
Kristin Mariah Pruitt, APRN-CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1265 S Utica Ave, Suite 300, Tulsa, OK 74104 Phone: 918-592-0999 Fax: 918-592-1021 | |
Ruth Ann Fritz, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 6465 S Yale Ave Ste 401, Tulsa, OK 74136 Phone: 918-561-6141 Fax: 918-582-3593 | |
Tammy Irene Joplin, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1923 S Utica Ave, Tulsa, OK 74104 Phone: 918-744-2769 | |
Julia Anne Jackson, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1422 E 71st St Ste B, Tulsa, OK 74136 Phone: 918-710-0422 Fax: 918-949-6681 |